Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rontal, Daniel
NCT05591989: Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects with Chronic Rhinitis (PARAGON)	Active, not recruiting	N/A	80	US	NEUROMARK System	Neurent Medical	Chronic Rhinitis	06/25	06/25
Good, Laura
NCT05918913: Expanded Access Program for Revumenib	Available	N/A		US	Revumenib, SNDX-5613	Syndax Pharmaceuticals	Relapsed/Refractory Acute Leukemia
NCT05591989: Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects with Chronic Rhinitis (PARAGON)	Active, not recruiting	N/A	80	US	NEUROMARK System	Neurent Medical	Chronic Rhinitis	06/25	06/25